Page 1

Table of Contents ㅁ X ㅁ ㅁ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 20 - F REGISTRATION STATEMENT PURSUANT TO SECTION 12 ( b ) OR ( g ) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report Commission file number 001-35773 RedHill Biopharma Ltd. ( Exact name of Registrant as specified in its charter ) N / A ( Translation of Registrant's name into English ) Israel ( Jurisdiction of incorporation or organization ) 21 Ha'arba'a Street , Tel Aviv 6473921 , Israel ( Address of principal executive offices ) Micha Ben Chorin , Chief Financial Officer 21 Ha'arba'a Street , Tel Aviv 6473921 , Israel Tel : 972-3-541-3131 ; Fax : 972-3-541-3144 ( Name , Telephone , E - mail and / or Facsimile number and Address of Company Contact Person ) Securities registered or to be registered pursuant to Section 12 ( b ) of the Act . Trading Symbol ( s ) RDHL Name of each exchange on which registered NASDAQ Global Market RDHL NASDAQ Global Market Title of class American Depositary Shares , each representing ten Ordinary Shares ( 1 ) Ordinary Shares , par value NIS 0.01 per share ( 2 ) ( 1 ) Evidenced by American Depositary Receipts . ( 2 ) Not for trading , but only in connection with the listing of the American Depositary Shares . Securities registered or to be registered pursuant to Section 12 ( g ) of the Act : None ( Title of Class ) Securities for which there is a reporting obligation pursuant to Section 15 ( d ) of the Act : None ( Title of Class ) Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report : 383,981,464 Ordinary Shares Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes No If this report is an annual or transition report , indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15 ( d ) of the Securities Exchange Act 1934 . Yes No x Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( §232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit such files ) . Yes No Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer or an emerging growth company . See definition of " accelerated filer and large accelerated filer " in Rule 12b - 2 of the Exchange Act .: Large Accelerated filer Accelerated filer Non - accelerated filer Emerging growth company If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards † provided pursuant to Section 13 ( a ) of the Exchange Act . † The term " new or revised financial accounting standard " refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5 , 2012 . Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C. 7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report . Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing : U.S. GAAP □ International Financing Reporting Standards as issued by the International Accounting Standards Board Other If " Other " has been checked in response to the previous question , indicate by check mark which financial statement item the registrant has elected to follow . Item 17 | Item 18 [ ] If this is an annual report , indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Exchange Act ) . Yes No